SS Innovations (NASDAQ: SSII) furnishes preliminary 2025 results and metrics

Rhea-AI Filing Summary

SS Innovations International, Inc. filed a current report to share that it has released preliminary, unaudited revenue and other selected operating metrics for the three and twelve months ended December 31, 2025. These figures were disclosed through a press release dated January 13, 2026, attached as Exhibit 99.1.

The company also provided an updated January 2026 Company Presentation as Exhibit 99.2, which it plans to use in communications with shareholders and the broader investment community. All of this information is being furnished under Items 2.02 and 7.01 of the report, meaning it is not treated as filed for liability purposes or automatically incorporated into other securities law filings.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

false 0001676163 0001676163 2026-01-13 2026-01-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 13, 2026

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Florida		001-42615		47-3478854
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

405, 3rd Floor, iLabs Info Technology Centre Udyog Vihar, Phase III Gurugram, Haryana India		122016
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: +91 73375 53469

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class		Trading Symbol		Name of each exchange on which registered
Common Stock		SSII		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

As used in this Current Report on Form 8-K (this “Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

Item 2.02 Results of Operations and Financial Condition.

The disclosure set forth in Item 7.01 of this Current Report is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

Preliminary Unaudited Revenue and Other Select Operating Metrics for the Quarter and Year Ended December 31, 2025

On January 13, 2026, the Company issued a press release announcing preliminary unaudited revenue and other select operating metrics for the three and twelve months ended December 31, 2025.

A copy of the press release is included with this Current Report as Exhibit 99.1.

January 2026 Company Presentation

Included with this Current Report as Exhibit 99.2 is an updated January 2026 Company Presentation (the “Presentation”), which SSi intends to use in communications to shareholders and the investment community.

Regulation FD Disclosure

The information set forth in Items 2.02 and 7.01 of this Current Report, in the press release included as Exhibit 99.1 to this Current Report, and in the Presentation included as Exhibit 99.2 to this Current Report, are deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information set forth in Items 2.02 and 7.01 of this Current Report, in the press release included as Exhibit 99.1 to this Current Report, and in the Presentation included as Exhibit 99.2 to this Current Report, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

Forward-Looking Statements

This Current Report, the press release included as Exhibit 99.1 to this Current Report, and the Presentation included as Exhibit 99.2 to this Current Report that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical statements of fact and statements regarding the Company’s intent, belief or expectations, including, but not limited to, statements regarding the Company’s fourth quarter 2025 and full year 2025 preliminary results, product development, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations and other statement that are predictive in nature. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SSi’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements.

1

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1*		Press Release, dated January 13, 2026
99.2*		January 2026 Company Presentation
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Furnished not filed

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 13, 2026	SS INNOVATIONS INTERNATIONAL, INC.
	By:	/s/ Sudhir Srivastava
		Sudhir Srivastava, M.D.
		Chairman and Chief Executive Officer

3

FAQ

What did SSII disclose in its latest 8-K filing?

The company furnished a press release with preliminary unaudited revenue and other select operating metrics for the quarter and year ended December 31, 2025, along with an updated January 2026 Company Presentation.

Which periods do SSII's preliminary results cover?

The preliminary unaudited revenue and selected operating metrics cover the three and twelve months ended December 31, 2025.

How did SSII provide its preliminary 2025 results to investors?

SS Innovations International, Inc. provided its preliminary 2025 results through a press release dated January 13, 2026, attached as Exhibit 99.1 to the report, and through an updated January 2026 Company Presentation attached as Exhibit 99.2.

Are SSII's preliminary results in this 8-K considered filed with the SEC?

No. The information in Items 2.02 and 7.01, the press release (Exhibit 99.1), and the presentation (Exhibit 99.2) is deemed furnished, not filed, and is not subject to Section 18 liabilities or automatic incorporation into other securities filings.

What is included as exhibits in SSII's January 13, 2026 8-K?

Exhibits include a press release dated January 13, 2026 (99.1), a January 2026 Company Presentation (99.2), and the Cover Page Interactive Data File (104).

What forward-looking information does SSII highlight in this report?

The report notes that non-historical statements, including those about fourth quarter 2025 and full year 2025 preliminary results, product development, clinical and regulatory timelines, market opportunity, and future operating results, are forward-looking and subject to risks and uncertainties.